Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intelligence
|
2093 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
cervical cancer
|
268 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.050 | 1.000 | 5 | 2012 | 2019 | |||||
Cervix carcinoma
|
283 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.050 | 1.000 | 5 | 2012 | 2019 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.050 | 0.400 | 5 | 2012 | 2016 | |||||
Malignant tumor of cervix
|
245 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.050 | 1.000 | 5 | 2012 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.030 | 1.000 | 3 | 2013 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.030 | 1.000 | 3 | 2013 | 2019 | |||||
Tuberculosis, Pulmonary
|
171 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.030 | 1.000 | 3 | 2014 | 2018 | |||||
Carcinogenesis
|
355 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||
Rheumatoid Arthritis
|
2387 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||
Autoimmune Diseases
|
428 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Bacterial Vaginosis
|
15 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Bronchiolitis
|
32 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Cancer of Digestive System
|
15 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
CATARACT, ANTERIOR POLAR
|
27 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Chronic gastritis
|
11 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Colon Carcinoma
|
275 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Community acquired pneumonia
|
13 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Endometrial Carcinoma
|
326 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Graves Disease
|
352 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Hepatitis
|
42 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Hepatitis A
|
27 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Hepatitis C
|
347 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Liver diseases
|
100 | 0.641 | 0.480 | 3 | 52227015 | intron variant | A/G | snv | 0.38 | 0.010 | 1 | 2019 | 2019 |